The Center for Diabetes Technology (CDT) has pursued a path to advance the use of technology, including analytics, to allow improved management, monitoring, and therapies for patients with Type 1 Diabetes.
Now, CDT is a recognized world leader in the technological treatment of diabetes and the hub of an international research network of leading U.S. institutions (Harvard, Stanford, Yale, Mayo Clinic, Mt. Sinai School of Medicine) and worldwide groups in Italy, France, Holland, and Argentina.
Welcoming Dr. K. Craig Kent, Chief Executive Officer, UVA Health and Executive Vice President, Health Affairs, to Center for Diabetes this fall on September 28, 2021. Dr. Kent met with the team members and learned more about recent news and accomplishments in the CDT research center.
The Center was recently honored by JDRF for its pioneering work in the development of Artificial Pancreas technology.
"Any sufficiently advanced technology is indistinguishable from Magic." -Arthur C. Clark
Researchers at the UVA Center for Diabetes Technology have spent years developing a smartphone that acts as an artificial pancreas – a device that automatically regulates blood sugar levels through customized insulin delivery.
Support our work and efforts to help fund innovative Type 1 Diabetes research.